Tag: Cancer: Leukemia
Polygenic Score Helps Guide Choice of Chemo for Pediatric AML
Polygenic score based on single nucleotide polymorphisms in the ara-C pathway genes may predict treatment outcomes
Prognostic Index May ID CLL Patients Who Will Not Need Treatment
Novel prognostic index CLL-WONT identifies patients with chronic lymphocytic leukemia who are at low risk for ever requiring treatment
Overall, Night Shift Work Not Tied to Higher Lymphoma Risk
However, nonlinear association seen between night shifts and chronic lymphocytic leukemia
Long-Term Outcomes Described for Survivors of Childhood ALL
Life challenges more negatively impacted in younger, female, relapsed patients; socializing more positively impacted in older patients
Global Burden of Chronic Lymphocytic Leukemia Up From 1990 to 2019
Incidence higher for men versus women, adults older than 70 years, and individuals living in high social-demographic index regions
Survival Increase Seen for Adults With Relapsed Ph+ ALL
From 2000 to 2019, overall survival progressively improved for patients with Philadelphia-positive ALL who had posttransplant relapse
Many Hospitals Lack All-Trans Retinoic Acid for Treating Leukemia
Only 14 percent of hospitals that referred patients with acute promyelocytic leukemia had ATRA readily available
Duration of Maintenance Therapy Studied in Childhood ALL
Vincristine and dexamethasone pulses might be eliminated during second year of treatment for children with low-risk disease
Ibrutinib + Venetoclax Promising for Chronic Lymphocytic Leukemia
Seventy-five percent of patients achieved a best response of bone marrow-undetectable measurable residual disease remission
1980 to 2017 Saw Improved Survival for Acute Myeloid Leukemia
Survival improved across calendar periods for all age groups except for patients aged ≥70 years